Historical Stock Price
ETFs Holding PRTK »    PRTK Split History »
Video: Compound Annual Growth Rate (CAGR) Definition


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Date Open High Low Close Volume
11/30/2021 $4.14 $4.25 $4.06 $4.22 295.60K
12/01/2021 $4.30 $4.34 $4.03 $4.07 292.80K
12/02/2021 $4.10 $4.37 $4.05 $4.14 210.20K
12/03/2021 $4.13 $4.20 $4.05 $4.08 201.00K
12/06/2021 $4.08 $4.36 $4.05 $4.28 272.30K
Paratek Pharmaceuticals is a commercial-stage biopharmaceutical company focused on the development and commercialization of therapies for diseases or other public health threats for civilian, government and military use. Co.'s U.S. Food and Drug Administration approved commercial product, NUZYRA® (omadacycline), is a once-daily oral and intravenous antibiotic for the treatment of adult patients with community-acquired bacterial pneumonia, and acute skin and skin structure infections caused by susceptible pathogens. SEYSARA® (sarecycline) is being marketed by Almirall, LLC in the U.S. as a new once-daily oral therapy for the treatment of moderate to severe acne vulgaris.
PRTK historical stock prices picture
Paratek Pharmaceuticals (PRTK) has the following price history information. Looking back at PRTK historical stock prices for the last five trading days, on November 30, 2021, PRTK opened at $4.14, traded as high as $4.25 and as low as $4.06, and closed at $4.22. Trading volume was a total of 295.60K shares. On December 01, 2021, PRTK opened at $4.30, traded as high as $4.34 and as low as $4.03, and closed at $4.07. Trading volume was a total of 292.80K shares. On December 02, 2021, PRTK opened at $4.10, traded as high as $4.37 and as low as $4.05, and closed at $4.14. Trading volume was a total of 210.20K shares. On December 03, 2021, PRTK opened at $4.13, traded as high as $4.20 and as low as $4.05, and closed at $4.08. Trading volume was a total of 201.00K shares. On December 06, 2021, PRTK opened at $4.08, traded as high as $4.36 and as low as $4.05, and closed at $4.28. Trading volume was a total of 272.30K shares.

PRTK Historical Stock Prices By Date:

PRTK historical cagr picture

Below, we examine the compound annual growth rate — CAGR for short — of an investment into Paratek Pharmaceuticals shares, starting with a $10,000 purchase of PRTK, and working forward through the historical stock price information to today.

Growth of $10,000.00
With Dividends Reinvested

Start date: 12/08/2011
End date: 12/06/2021
Start price/share: $82.20
End price/share: $4.28
Starting shares: 121.65
Ending shares: 404.77
Dividends reinvested/share: $31.97
Total return: -82.68%
Average Annual Total Return: -16.08%
Starting investment: $10,000.00
Ending investment: $1,731.59
Years: 10.00
 
Growth of $10,000.00
Without Dividends Reinvested

Start date: 12/08/2011
End date: 12/06/2021
Start price/share: $82.20
End price/share: $4.28
Dividends collected/share: $31.97
Total return: -55.90%
Average Annual Total Return: -7.86%
Starting investment: $10,000.00
Ending investment: $4,409.45
Years: 10.00
Date Close
11/30/2021$4.22
12/01/2021$4.07
12/02/2021$4.14
12/03/2021$4.08
12/06/2021$4.28
PRTK is categorized under the Healthcare sector; below are some other companies in the same sector:

PRTO Historical Stock Prices
PRXL Historical Stock Prices
PSDV Historical Stock Prices
PSTI Historical Stock Prices
PTBI Historical Stock Prices
PTCT Historical Stock Prices
PTGX Historical Stock Prices
PTI Historical Stock Prices
PTIE Historical Stock Prices
PTLA Historical Stock Prices

Also explore: PRTK shares outstanding history

Email EnvelopeFree PRTK Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts

PRTK Historical Stock Prices | www.HistoricalStockPrice.com | Copyright © 2013 - 2021, All Rights Reserved

Nothing in www.HistoricalStockPrice.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.